{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:40:33Z","timestamp":1787784033990,"version":"build-2784847793"},"reference-count":62,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:p>Onychomycosis is a common, difficult-to-treat nail infection that is mainly caused by dermatophytes. Current therapies are not wholly effective and are associated with manifold side effects.<\/jats:p>","DOI":"10.1128\/aac.02117-18","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T11:10:03Z","timestamp":1552043403000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":36,"title":["Improved Methods for Assessing Therapeutic Potential of Antifungal Agents against Dermatophytes and Their Application in the Development of NP213, a Novel Onychomycosis Therapy Candidate"],"prefix":"10.1128","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8950-0076","authenticated-orcid":false,"given":"Derry K.","family":"Mercer","sequence":"first","affiliation":[{"name":"NovaBiotics, Ltd., Craibstone, Aberdeen, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin S.","family":"Stewart","sequence":"additional","affiliation":[{"name":"NovaBiotics, Ltd., Craibstone, Aberdeen, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Miller","sequence":"additional","affiliation":[{"name":"NovaBiotics, Ltd., Craibstone, Aberdeen, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Robertson","sequence":"additional","affiliation":[{"name":"NovaBiotics, Ltd., Craibstone, Aberdeen, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa M. S.","family":"Duncan","sequence":"additional","affiliation":[{"name":"NovaBiotics, Ltd., Craibstone, Aberdeen, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"O\u2019Neil","sequence":"additional","affiliation":[{"name":"NovaBiotics, Ltd., Craibstone, Aberdeen, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010031.pub2"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.04.062"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.149.s65.5.x"},{"key":"e_1_3_3_5_2","first-page":"s96","article-title":"Onchomycosis: an overview","volume":"12","author":"Elewski BE","year":"2013","unstructured":"Elewski BE, Rich P, Tosti A, Pariser DM, Scher R, Daniel RC, Gupta AK. 2013. Onchomycosis: an overview. J Drugs Dermatol 12:s96\u2013103.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_3_6_2","first-page":"604","article-title":"Different physicochemical properties of antimycotic agents are relevant for penetration into and through human nails","volume":"61","author":"Neubert RH","year":"2006","unstructured":"Neubert RH, Gensbugel C, Jackel A, Wartewig S. 2006. Different physicochemical properties of antimycotic agents are relevant for penetration into and through human nails. Pharmazie 61:604\u2013607.","journal-title":"Pharmazie"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/13693780310001656803"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/13693780802577892"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.12.3797-3801.2002"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12118"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.09.010"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15063"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12191"},{"key":"e_1_3_3_14_2","volume-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard","author":"CLSI","year":"2008","unstructured":"CLSI. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard, 2nd ed (M38-A2). Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"2"},{"key":"e_1_3_3_15_2","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard","author":"CLSI","year":"2008","unstructured":"CLSI. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard, third edition; 3rd ed (M27-A3). Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"3"},{"key":"e_1_3_3_16_2","first-page":"398","article-title":"EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts","volume":"2008","author":"EUCAST","year":"2008","unstructured":"EUCAST. 2008. EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect 2008:398\u2013405.","journal-title":"Clin Microbiol Infect"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2016.10.017"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.29"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.12.213"},{"key":"e_1_3_3_20_2","first-page":"37","volume-title":"Topical nail products and ungual drug delivery","author":"Hao J","year":"2013","unstructured":"Hao J, Li SK. 2013. Permeability of the nail plate, p 37\u201360. In Murthy SN, Maibach HI (ed), Topical nail products and ungual drug delivery. CRC Press, Boca Raton, FL."},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2003.11.008"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1997.tb06127.x"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2014.10.003"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myx160:myx160-myx160"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-008-9105-4"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019802"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1134"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1159\/000073086"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.10.3371-3372.2003"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0933-7407.2003.00932.x"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12369"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1159\/000093862"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.46474-0"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70482-7"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.2174\/1568026615666150703121700"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1177\/002215549704500107"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmr.1032"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.55.1.2"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01985-09"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis473"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.05-4406com"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2017.05.026"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2017.08.022"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.05.021"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12592"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2010.03.037"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/9781555817381.ch123"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00418-008-0435-6"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1021\/pr1009349"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1996.tb00103.x"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.1.139-143.1997"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00111-14"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02554-16"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2013.01.015"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2015.03.009"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.62.06.0009"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00083-11"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.6.1694-1696.2000"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-129-33264"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(91)90021-7"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1968.tb20277.x"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.5.1111"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.6.1805-1817.2003"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02117-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02117-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:30:14Z","timestamp":1645479014000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02117-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1128\/AAC.02117-18"],"URL":"https:\/\/doi.org\/10.1128\/aac.02117-18","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"2018-10-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02117-18"}}